CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 39 enrolled
Drug / intervention
Vitamin D (cholecalciferol) +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00914810
NCT00914810Phase 3Completed
CompareCT.gov

Effect of Supplemental Vitamin D on Skeletal Muscle Function in COPD Patients.

Minneapolis Veterans Affairs Medical Center·interventional·Posted Jun 5, 2009·Updated Jun 11, 2013

In Brief

A Phase 3 clinical trial evaluating Vitamin D (cholecalciferol) and Placebo for Chronic Obstructive Pulmonary Disease (COPD). Completed, enrolled 39 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether or not vitamin D supplementation can improve physical performance in persons with severe chronic obstructive pulmonary disease (COPD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease (COPD)
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 5, 2009
Enrollment StartJun 1, 2009
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.1 years ago

Interventions

Vitamin D (cholecalciferol)dietary

2000 I.U. daily for 6 weeks

Placebodietary

Placebo (sugar pill) daily for 6 weeks